https://www.live-feeds.com/feed/pfizer-ceo-bourla-bets-the-viagra-playbook-can-crack-the-obesity-marketContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/pfizer-ceo-bourla-bets-the-viagra-playbook-can-crack-the-obesity-markethttps://www.live-feeds.com/feed/pfizer-ceo-bourla-bets-the-viagra-playbook-can-crack-the-obesity-market#u191147Tue, 10 Nov 2026 12:35:22 +0000Pfizer raised its 2026 financial forecasts and profit outlook following strong third-quarter performance driven by products such as Eliquis and various cancer drugs. Simultaneously, CEO Albert Bourla outlined a strategy to leverage lessons from the historical commercial success of Viagra to position the company in the competitive obesity and GLP-1 treatment markets, including initial commercialization efforts in China. The updated projections arrive as Big Pharma capital allocation shifts heavily toward metabolic medicine and next-generation cardiometabolic therapies.Why it mattersThe pharmace